News GSK passes to Magic Johnson for RSV awareness drive GSK said basketball legend will help spark “important conversations” about RSV in older adults.
News GSK hits back in 5-in-1 meningitis jab contest with Pfizer Phase 3 trial sets up filing for GSK's MenABCWY vaccine, several months later than its rival.
News Mersana stung by FDA hold on STING drug Death in ph1 trial casts a pall over GSK-backed project, licensed for $100m upfront last year.
News GSK wins the vote contest in FDA’s RSV vaccine panels Advisory committee votes unanimously that RSVPreF3 shot is effective, and 10-2 on safety.
News Pfizer’s RSV shot clears FDA adcomm; now it’s GSK’s turn There was debate about cases of Guillain Barré and the population of the phase 3 RENOIR trial.
News GSK scores regular FDA approval for PD-1 inhibitor Jemperli The checkpoint inhibitor secured confirmatory approval after an accelerated nod back in 2021.
News Court sides with EU on decision to revoke Ocaliva's license Advanz Pharma's bid to keep its Ocaliva treatment for rare liver disease primary biliary cholangitis (PBC) on the EU market has ended in failure
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
